Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammography | 35 | 2026 | 296 | 5.540 |
Why?
|
| Cone-Beam Computed Tomography | 13 | 2026 | 73 | 2.520 |
Why?
|
| Breast | 15 | 2026 | 194 | 2.420 |
Why?
|
| Radiographic Image Enhancement | 19 | 2017 | 99 | 2.410 |
Why?
|
| Breast Neoplasms | 18 | 2021 | 1235 | 1.880 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2020 | 1663 | 1.880 |
Why?
|
| Image Processing, Computer-Assisted | 13 | 2026 | 715 | 1.310 |
Why?
|
| Radiometry | 7 | 2022 | 39 | 1.290 |
Why?
|
| Radiation Dosage | 15 | 2022 | 140 | 1.230 |
Why?
|
| Algorithms | 15 | 2022 | 1060 | 1.140 |
Why?
|
| Phantoms, Imaging | 16 | 2026 | 242 | 1.090 |
Why?
|
| Radiation Protection | 2 | 2019 | 27 | 0.970 |
Why?
|
| Models, Theoretical | 4 | 2014 | 274 | 0.830 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 7 | 2012 | 76 | 0.810 |
Why?
|
| X-Ray Diffraction | 2 | 2014 | 62 | 0.810 |
Why?
|
| Gold | 2 | 2019 | 235 | 0.600 |
Why?
|
| Monte Carlo Method | 12 | 2022 | 102 | 0.600 |
Why?
|
| Artifacts | 1 | 2020 | 130 | 0.590 |
Why?
|
| Metal Nanoparticles | 2 | 2019 | 191 | 0.580 |
Why?
|
| X-Rays | 8 | 2019 | 47 | 0.540 |
Why?
|
| Models, Biological | 3 | 2007 | 1193 | 0.530 |
Why?
|
| Imaging, Three-Dimensional | 8 | 2019 | 312 | 0.510 |
Why?
|
| Tomography | 2 | 2007 | 9 | 0.510 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2020 | 190 | 0.480 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 274 | 0.420 |
Why?
|
| Histocytochemistry | 1 | 2013 | 48 | 0.390 |
Why?
|
| Terahertz Imaging | 1 | 2013 | 11 | 0.390 |
Why?
|
| Scattering, Radiation | 6 | 2017 | 72 | 0.390 |
Why?
|
| Biomimetics | 1 | 2013 | 33 | 0.380 |
Why?
|
| Photometry | 1 | 2012 | 7 | 0.370 |
Why?
|
| Radiography | 2 | 2015 | 559 | 0.370 |
Why?
|
| Equipment Design | 10 | 2026 | 374 | 0.360 |
Why?
|
| Humans | 44 | 2026 | 65845 | 0.340 |
Why?
|
| Relative Biological Effectiveness | 2 | 2007 | 7 | 0.330 |
Why?
|
| Female | 29 | 2026 | 34425 | 0.320 |
Why?
|
| Risk Assessment | 3 | 2013 | 2116 | 0.320 |
Why?
|
| Organ Specificity | 2 | 2007 | 201 | 0.310 |
Why?
|
| Signal-To-Noise Ratio | 3 | 2020 | 67 | 0.310 |
Why?
|
| Computer Simulation | 8 | 2016 | 488 | 0.300 |
Why?
|
| Tomography, Spiral Computed | 1 | 2008 | 22 | 0.270 |
Why?
|
| Whole-Body Counting | 1 | 2007 | 4 | 0.270 |
Why?
|
| Mass Screening | 1 | 2012 | 700 | 0.240 |
Why?
|
| Photons | 2 | 2016 | 23 | 0.230 |
Why?
|
| Film Dosimetry | 2 | 2015 | 10 | 0.230 |
Why?
|
| Linear Models | 5 | 2020 | 405 | 0.200 |
Why?
|
| Feasibility Studies | 4 | 2020 | 593 | 0.190 |
Why?
|
| Sensitivity and Specificity | 8 | 2017 | 1172 | 0.180 |
Why?
|
| Rib Fractures | 1 | 2002 | 23 | 0.180 |
Why?
|
| Equipment Failure Analysis | 4 | 2013 | 79 | 0.180 |
Why?
|
| Child Abuse | 1 | 2002 | 89 | 0.170 |
Why?
|
| Reproducibility of Results | 7 | 2017 | 1719 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2011 | 2324 | 0.150 |
Why?
|
| Medical Staff | 1 | 2019 | 13 | 0.150 |
Why?
|
| ROC Curve | 3 | 2013 | 295 | 0.150 |
Why?
|
| Calcinosis | 3 | 2014 | 84 | 0.140 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 206 | 0.130 |
Why?
|
| Body Burden | 2 | 2007 | 12 | 0.130 |
Why?
|
| Retrospective Studies | 6 | 2022 | 6957 | 0.120 |
Why?
|
| Tellurium | 1 | 2016 | 5 | 0.120 |
Why?
|
| Cadmium Compounds | 1 | 2016 | 25 | 0.120 |
Why?
|
| Reference Values | 1 | 2017 | 330 | 0.120 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2016 | 23 | 0.120 |
Why?
|
| Electric Conductivity | 1 | 2016 | 52 | 0.120 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2016 | 140 | 0.110 |
Why?
|
| Utah | 1 | 2015 | 6 | 0.110 |
Why?
|
| Germany | 1 | 2015 | 57 | 0.110 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2006 | 101 | 0.110 |
Why?
|
| Electrons | 1 | 2015 | 33 | 0.110 |
Why?
|
| Time Factors | 2 | 2020 | 3779 | 0.110 |
Why?
|
| Interferometry | 1 | 2014 | 4 | 0.110 |
Why?
|
| Transducers | 2 | 2005 | 24 | 0.110 |
Why?
|
| Congresses as Topic | 1 | 2015 | 78 | 0.110 |
Why?
|
| Abdominal Cavity | 1 | 2014 | 7 | 0.100 |
Why?
|
| Fats | 1 | 2014 | 20 | 0.100 |
Why?
|
| Angiography | 2 | 2004 | 154 | 0.100 |
Why?
|
| Capsule Endoscopy | 1 | 2014 | 40 | 0.100 |
Why?
|
| Thoracic Vertebrae | 1 | 2013 | 35 | 0.100 |
Why?
|
| Tin | 1 | 2012 | 3 | 0.100 |
Why?
|
| Spectrum Analysis | 1 | 2013 | 50 | 0.090 |
Why?
|
| Pattern Recognition, Automated | 1 | 2012 | 53 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2014 | 115 | 0.090 |
Why?
|
| Fluoroscopy | 3 | 2015 | 69 | 0.090 |
Why?
|
| Orthopedic Procedures | 1 | 2013 | 55 | 0.090 |
Why?
|
| Safety | 1 | 2013 | 142 | 0.090 |
Why?
|
| Skin | 2 | 2013 | 436 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2013 | 134 | 0.090 |
Why?
|
| Lumbar Vertebrae | 1 | 2013 | 178 | 0.080 |
Why?
|
| Models, Anatomic | 3 | 2016 | 63 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 1 | 2013 | 253 | 0.080 |
Why?
|
| Breast Diseases | 2 | 2014 | 45 | 0.080 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2011 | 44 | 0.080 |
Why?
|
| Research | 1 | 2011 | 195 | 0.080 |
Why?
|
| Contrast Media | 2 | 2009 | 435 | 0.070 |
Why?
|
| Liver | 1 | 2014 | 875 | 0.070 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2009 | 55 | 0.070 |
Why?
|
| Radionuclide Imaging | 1 | 2008 | 129 | 0.070 |
Why?
|
| Doxorubicin | 1 | 2009 | 98 | 0.070 |
Why?
|
| Uterus | 1 | 2008 | 41 | 0.070 |
Why?
|
| Radiographic Magnification | 1 | 2007 | 2 | 0.070 |
Why?
|
| Fractals | 1 | 2007 | 8 | 0.060 |
Why?
|
| Genes, BRCA2 | 1 | 2007 | 13 | 0.060 |
Why?
|
| Genes, BRCA1 | 1 | 2007 | 18 | 0.060 |
Why?
|
| Forecasting | 1 | 2008 | 231 | 0.060 |
Why?
|
| Thymus Gland | 1 | 2008 | 241 | 0.060 |
Why?
|
| Bone and Bones | 1 | 2008 | 152 | 0.060 |
Why?
|
| Computer-Aided Design | 1 | 2006 | 27 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2008 | 491 | 0.060 |
Why?
|
| X-Ray Intensifying Screens | 2 | 2002 | 8 | 0.060 |
Why?
|
| Heart | 1 | 2008 | 298 | 0.060 |
Why?
|
| Obesity | 1 | 2014 | 1281 | 0.060 |
Why?
|
| Risk Factors | 3 | 2013 | 5475 | 0.050 |
Why?
|
| Organ Size | 2 | 2016 | 175 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 737 | 0.050 |
Why?
|
| Animals | 2 | 2019 | 21493 | 0.050 |
Why?
|
| Lung | 1 | 2008 | 969 | 0.050 |
Why?
|
| Adult | 5 | 2015 | 17579 | 0.050 |
Why?
|
| Autopsy | 1 | 2002 | 56 | 0.050 |
Why?
|
| Middle Aged | 6 | 2015 | 18501 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 49 | 0.040 |
Why?
|
| Mutation | 1 | 2007 | 2675 | 0.040 |
Why?
|
| Multimodal Imaging | 1 | 2019 | 74 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2016 | 29 | 0.030 |
Why?
|
| Polymethyl Methacrylate | 1 | 2016 | 15 | 0.030 |
Why?
|
| Alloys | 1 | 2016 | 30 | 0.030 |
Why?
|
| Wrist | 1 | 2016 | 39 | 0.030 |
Why?
|
| Software | 2 | 2014 | 401 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2009 | 606 | 0.030 |
Why?
|
| Fingers | 1 | 2016 | 49 | 0.030 |
Why?
|
| Blood Vessels | 1 | 2016 | 63 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2014 | 3340 | 0.030 |
Why?
|
| Electrodes | 1 | 2015 | 39 | 0.030 |
Why?
|
| Mesophyll Cells | 1 | 2014 | 2 | 0.030 |
Why?
|
| Aged | 4 | 2014 | 15147 | 0.030 |
Why?
|
| Thermoluminescent Dosimetry | 1 | 2013 | 3 | 0.020 |
Why?
|
| Prone Position | 1 | 2013 | 28 | 0.020 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2013 | 14 | 0.020 |
Why?
|
| Body Size | 1 | 2013 | 20 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2013 | 38 | 0.020 |
Why?
|
| Color | 1 | 2012 | 26 | 0.020 |
Why?
|
| Georgia | 1 | 2012 | 92 | 0.020 |
Why?
|
| Child | 1 | 2002 | 4653 | 0.020 |
Why?
|
| Lead | 1 | 2012 | 46 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 327 | 0.020 |
Why?
|
| Stents | 1 | 2016 | 500 | 0.020 |
Why?
|
| Fuzzy Logic | 1 | 2011 | 5 | 0.020 |
Why?
|
| Anisotropy | 1 | 2011 | 63 | 0.020 |
Why?
|
| Diffusion | 1 | 2011 | 83 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2013 | 401 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 267 | 0.020 |
Why?
|
| Light | 1 | 2011 | 195 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1117 | 0.020 |
Why?
|
| Muscles | 1 | 2011 | 179 | 0.020 |
Why?
|
| Iodine | 1 | 2009 | 21 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 1454 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2011 | 301 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 498 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 899 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2006 | 60 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 2005 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2005 | 127 | 0.010 |
Why?
|
| Systems Theory | 1 | 2004 | 4 | 0.010 |
Why?
|
| Semiconductors | 1 | 2004 | 14 | 0.010 |
Why?
|
| Biophysical Phenomena | 1 | 2004 | 23 | 0.010 |
Why?
|
| Biophysics | 1 | 2004 | 42 | 0.010 |
Why?
|
| Data Compression | 1 | 2004 | 9 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2002 | 41 | 0.010 |
Why?
|
| Nanoparticles | 1 | 2009 | 553 | 0.010 |
Why?
|
| Male | 2 | 2014 | 31410 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2002 | 77 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 5682 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2004 | 312 | 0.010 |
Why?
|